about
Dendritic cells release HLA-B-associated transcript-3 positive exosomes to regulate natural killer functionOncogene withdrawal engages the immune system to induce sustained cancer regression.On the traces of XPD: cell cycle matters - untangling the genotype-phenotype relationship of XPD mutationsAn essential role for the immune system in the mechanism of tumor regression following targeted oncogene inactivation.Benzo pyrene-induced DNA adducts and gene expression profiles in target and non-target organs for carcinogenesis in mice.RAE1 ligands for the NKG2D receptor are regulated by STING-dependent DNA sensor pathways in lymphomaThe oxidative demethylase ALKBH3 marks hyperactive gene promoters in human cancer cellsClinical and pathological implications of concurrent autoimmune thyroid disorders and papillary thyroid cancerATM-dependent spontaneous regression of early Eμ-myc-induced murine B-cell leukemia depends on natural killer and T cellsMicroRNAs miR-186 and miR-150 down-regulate expression of the pro-apoptotic purinergic P2X7 receptor by activation of instability sites at the 3'-untranslated region of the gene that decrease steady-state levels of the transcriptThe Glycophosphatidylinositol Anchor of the MCMV Evasin, m157, Facilitates Optimal Cell Surface Expression and Ly49 Receptor Recognition.Interplay between DNA repair and inflammation, and the link to cancerSlp-76 is a critical determinant of NK-cell mediated recognition of missing-self targets.Microenvironment abnormalities and lymphomagenesis: Immunological aspects.Immune microenvironment in tumor progression: characteristics and challenges for therapyAn ENU mutagenesis approach to dissect "self"-induced immune responses: Unraveling the genetic footprint of immunosurveillance.The anticancer immune response: indispensable for therapeutic success?p53 stabilization in response to DNA damage requires Akt/PKB and DNA-PK.Increased serum NKG2D-ligands and downregulation of NKG2D in peripheral blood NK cells of patients with major burns.DNA damage response and development of targeted cancer treatments.ATM activation mediates anticancer immunosurveillance by natural killer and T cellsUse of gene expression profiles of peripheral blood lymphocytes to distinguish BRCA1 mutation carriers in high risk breast cancer families.Hematopoietic SCT from partially HLA-mismatched (HLA-haploidentical) related donors.Essential role of the Ly49A stalk region for immunological synapse formation and signaling.P2X(7) receptor expression is decreased in epithelial cancer cells of ectodermal, uro-genital sinus, and distal paramesonephric duct origin.Regulation of P2X(7) gene transcription.Chlorogenic acid prevents isoproterenol-induced DNA damage in vascular smooth muscle cellsControlling natural killer cell responses: integration of signals for activation and inhibition.P2X7-mediated chemoprevention of epithelial cancers.Stimulating natural killer cells to protect against cancer: recent developments.Targeting NKG2D in tumor surveillance.Regulation of self-ligands for activating natural killer cell receptors.How virus persistence can initiate the tumorigenesis process.Nonblocking Monoclonal Antibody Targeting Soluble MIC Revamps Endogenous Innate and Adaptive Antitumor Responses and Eliminates Primary and Metastatic Tumors.DNA damage response and evasion from immunosurveillance in CLL: new options for NK cell-based immunotherapies.The DNA damage response induces antigen presenting cell-like functions in fibroblasts.Differential expression profile analysis of DNA damage repair genes in CD133+/CD133- colorectal cancer cells.How to develop better screens for anti-cancer therapies?New prospects on the NKG2D/NKG2DL system for oncology.Transcriptional signature of lymphoblastoid cell lines of BRCA1, BRCA2 and non-BRCA1/2 high risk breast cancer families.
P2860
Q28854563-5138E6B0-6E95-4F4E-91B9-C55BE6B4F192Q33987633-8FF050AA-E194-4372-93A6-5A160E97D2F9Q34174006-DAB99504-F1F8-4F0C-9A0F-4675D20E747CQ34361976-BB1F4387-4243-454A-B938-D6ECFA73F645Q34402066-AD0D505B-C96D-4475-B451-F5E665861F0BQ34407976-9F967BA0-FB22-4DA7-A7D1-3FA86E457B36Q34487363-1A4C620A-D268-4E45-8CF1-ACC20268D9CFQ34595104-75F51F91-246F-4D1B-BD7C-6CD92969D161Q34660118-FB3A2D1C-0288-464A-89F8-4BB4B1151D0EQ34804590-C8A70B4E-F210-40BB-8CDD-B6F520CACCB3Q34806981-D04AB41D-016A-4AAE-A8C4-41967A821ECAQ34989590-10BC1891-223B-41FB-8349-47A612DC145BQ35832525-BC8728DD-F9D4-4D4F-81AE-6B021FA80884Q36118020-E2687EE7-3E73-4754-8A9E-DB4076CD455EQ36178400-FF34F2C3-2B9F-40BD-889B-BE27C83FDE20Q36373362-CAB2DF98-9FE7-4EB4-A401-12E7278744DFQ36677608-35D060FE-F35F-43C1-965A-6F69A9C27648Q36693887-F9A769C6-14FE-4AC0-BBA9-09E299A69774Q36771770-3AAA029D-1F33-4456-A9BD-173DB38C6C23Q36939423-5906A0FF-12E5-458E-974C-6A3CF75E06AEQ37028006-00C745B7-36F2-490A-BD65-8C8561A4B0DFQ37148659-5E04FCC2-B57B-4613-8234-31CCA7D9CDFCQ37235006-CAD8E355-FB79-44D5-80C8-F8562E0BDE26Q37257026-7BA59719-4E80-4D99-A41B-4C1C4D6637D2Q37279471-D3221EE2-AD94-4475-8B79-9F6B6142EC19Q37279475-4477489F-68D7-4D7F-8746-3EF398DA0232Q37403182-CA292428-E26B-4538-BDBE-F73A03481C05Q37404156-FBE1E2DA-54F2-4C9A-81C7-3F59BB51E6C1Q37618815-F94F91C2-FA28-4CB3-81F0-5884436FE104Q37877269-31D87EB8-2995-44C6-86D2-813D48473519Q38005176-DB8817DA-67AE-4A70-BAFE-BDF0D3B52B69Q38108820-BD5656A4-6E96-4DCB-B58B-76141558136AQ38156891-C88A0408-9BB8-4B57-94F9-09A2DDB37B8BQ38860610-5591C25D-E59C-4E43-846B-43F4A055EA6DQ39037081-355A26F6-53A5-40DA-B030-AF7B214CAD84Q39038723-830912AC-E791-45D5-B694-06F528000099Q41144456-FFBA6A18-F08B-4FFA-807B-943C00BD967FQ42025977-2114D1BA-4F21-4C91-83D5-A91C15604EFDQ42796257-6DF4D94E-409A-424E-B7B7-C2AD5770E6A2Q45784223-2FA09B6F-62DF-4B0E-917E-1B7077658AED
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The DNA damage response, immunity and cancer.
@ast
The DNA damage response, immunity and cancer.
@en
type
label
The DNA damage response, immunity and cancer.
@ast
The DNA damage response, immunity and cancer.
@en
prefLabel
The DNA damage response, immunity and cancer.
@ast
The DNA damage response, immunity and cancer.
@en
P1476
The DNA damage response, immunity and cancer.
@en
P304
P356
10.1016/J.SEMCANCER.2006.07.004
P577
2006-07-07T00:00:00Z